In this study, we have found that the mRNA expression levels of the ligands for immune checkpoint receptors PD-1 and CTLA-4—namely, PD-L1 and PD-L2; CD80 and CD86, respectively— were all significantly higher in pituitary adenomas than in the normal human pituitary. Here, PDCD1LG2 is linked to pituitary gland adenoma.